Volunteer Receives An Experimental Universal Influenza Vaccine Known as H1ssF_3928 (IMAGE)

NIH/National Institute of Allergy and Infectious Diseases

Volunteer Receives An Experimental Universal Influenza Vaccine Known as H1ssF_3928

Caption

A healthy volunteer receives an experimental universal influenza vaccine known as H1ssF_3928 as part of a Phase 1 clinical trial at the NIH Clinical Center in Bethesda, Maryland. Scientists at NIAID's Vaccine Research Center (VRC) developed the vaccine and are leading the clinical trial. Floreliz Mendoza, nurse specialist and study coordinator at the VRC Clinical Trials Program performs the vaccination as trial principal investigator, Dr. Grace Chen, VRC Clinical Trials Program, observes.

Credit

NIAID

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.